EPIC Early Detection of Ovarian Cancer (Clincal Cancer Research) eg. CA125; HE4 Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, July 16, 2016

EPIC Early Detection of Ovarian Cancer (Clincal Cancer Research) eg. CA125; HE4



abstract
 
CA125 dominated performance for ovarian cancer early detection amongst four serum biomarkers evaluated in EPIC study pre-diagnostic serum, elevating on average 3 years prior to detection. Adding HE4 provided only marginal improvement. This natural history supports annual testing for early detection and highlights the importance of biomarker discovery complementing CA125.

0 comments :

Post a Comment

Your comments?